JENNIFER BUNKER: Open Payments
NPI 1114354834 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 23 payments from 5 companies in 2025. Trend: 2023 $372 · 2024 $143 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $187 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
Products named: DUPIXENT, Rhapsido, NEFFY, CUVITRU, TEZSPIRE.
Industry payments across UT — which companies pay providers there.
